Disease mongering in drug promotion: do governments have a regulatory role?
Mintzes
Barbara
B
Therapeutics Initiative, Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada. bmintzes@chspr.ubc.ca
D000329:Advertising; D001364:Awareness; D002908:Chronic Disease; D003256:Community Participation; D003643:Death; D004345:Drug Industry; D005239:Fear; D006291:Health Policy; D020249:Hormone Replacement Therapy; D006801:Humans; D007880:Legislation, Drug; D008593:Menopause; D011634:Public Health; D012109:Research Support as Topic; D014481:United States; D014486:United States Food and Drug Administration